MARKET

CYPH

CYPH

Cypherpunk Technologies Inc
NASDAQ
1.270
+0.180
+16.51%
After Hours: 1.318 +0.048 +3.78% 19:58 05/20 EDT
OPEN
1.090
PREV CLOSE
1.090
HIGH
1.310
LOW
1.070
VOLUME
6.26M
TURNOVER
--
52 WEEK HIGH
3.700
52 WEEK LOW
0.2323
MARKET CAP
135.21M
P/E (TTM)
-1.8494
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CYPH last week (0511-0515)?
Weekly Report · 2d ago
Cypherpunk Technologies GAAP EPS of -$0.46
Seeking Alpha · 6d ago
Cypherpunk Technologies Q1 net loss widens
Reuters · 6d ago
Cypherpunk Technologies Reports First Quarter 2026 Financial Results
PR Newswire · 6d ago
Weekly Report: what happened at CYPH last week (0504-0508)?
Weekly Report · 05/11 09:34
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 05/06 12:06
Weekly Report: what happened at CYPH last week (0427-0501)?
Weekly Report · 05/04 09:33
Weekly Report: what happened at CYPH last week (0420-0424)?
Weekly Report · 04/27 09:34
More
About CYPH
Cypherpunk Technologies Inc., formerly Leap Therapeutics, Inc., is engaged in developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The Company focuses on the development of sirexatamab and FL-501 to treat patients with cancer. Zcash is a privacy-preserving blockchains, launched as a fork of Bitcoin with advanced cryptography that enables selective transparency. Zcash has introduced privacy technology through the use of zero-knowledge proofs (zk-SNARKs), allowing transactions to be verified without revealing sender, receiver, or amount. FL-501 is a potential class antibody designed to neutralize GDF-15 and prevent the binding to its receptor. sirexatamab (DKN-01), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. Sirexatamab is being developed in patients with esophagogastric, gynecologic, and colorectal cancers.

Webull offers Cypherpunk Technologies Inc stock information, including NASDAQ: CYPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CYPH stock methods without spending real money on the virtual paper trading platform.